Does AD26.COV2.S Cause Myocardial infarction? 5 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 5 reports of Myocardial infarction have been filed in association with AD26.COV2.S. This represents 1.2% of all adverse event reports for AD26.COV2.S.
5
Reports of Myocardial infarction with AD26.COV2.S
1.2%
of all AD26.COV2.S reports
0
Deaths
4
Hospitalizations
How Dangerous Is Myocardial infarction From AD26.COV2.S?
Of the 5 reports, 4 (80.0%) required hospitalization.
Is Myocardial infarction Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for AD26.COV2.S. However, 5 reports have been filed with the FAERS database.
What Other Side Effects Does AD26.COV2.S Cause?
Covid-19 (58)
Fatigue (47)
Off label use (43)
Headache (42)
Pain (41)
Pyrexia (40)
Malaise (38)
Arthralgia (32)
Chills (31)
Nausea (25)
What Other Drugs Cause Myocardial infarction?
ROSIGLITAZONE (17,018)
TESTOSTERONE (3,396)
ADALIMUMAB (3,214)
SACUBITRIL\VALSARTAN (3,120)
CALCIUM\DEXTROSE\MAGNESIUM\SODIUM\SODIUM (2,391)
APIXABAN (2,010)
TICAGRELOR (1,749)
LENALIDOMIDE (1,712)
ETANERCEPT (1,693)
METFORMIN\ROSIGLITAZONE (1,640)
Which AD26.COV2.S Alternatives Have Lower Myocardial infarction Risk?
AD26.COV2.S vs ADAGRASIB
AD26.COV2.S vs ADALIMUMAB
AD26.COV2.S vs ADALIMUMAB-AACF
AD26.COV2.S vs ADALIMUMAB-AATY
AD26.COV2.S vs ADALIMUMAB-ADAZ